Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Arterial Thrombosis - Overview
Arterial Thrombosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Arterial Thrombosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Arterial Thrombosis - Companies Involved in Therapeutics Development
Anthos Therapeutics Inc
Astellas Pharma Inc
GLSynthesis Inc
Jiangsu Hengrui Medicine Co Ltd
MDI Therapeutics Inc
Oasis Pharmaceuticals LLC
Protheragen Inc
Arterial Thrombosis - Drug Profiles
abelacimab [INN] - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ASP-6537 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GLS-409 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDI-2517 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
OA-150 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptide to Inhibit PAI-1 for Arterial Thrombosis and Pulmory Thromboembolism - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-007867 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SHR-2285 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit Integrin alpha 2 beta 1 for Arterial Thrombosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit NMMHC IIA for Arterial Thrombosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Factor XIa for Arterial Thrombosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Arterial Thrombosis - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Arterial Thrombosis, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Arterial Thrombosis, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Arterial Thrombosis - Pipeline by Anthos Therapeutics Inc, H2 2020
Arterial Thrombosis - Pipeline by Astellas Pharma Inc, H2 2020
Arterial Thrombosis - Pipeline by GLSynthesis Inc, H2 2020
Arterial Thrombosis - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2020
Arterial Thrombosis - Pipeline by MDI Therapeutics Inc, H2 2020
Arterial Thrombosis - Pipeline by Oasis Pharmaceuticals LLC, H2 2020
Arterial Thrombosis - Pipeline by Protheragen Inc, H2 2020
Arterial Thrombosis - Dormant Projects, H2 2020
Arterial Thrombosis - Dormant Projects, H2 2020 (Contd..1), H2 2020